Orexo AB - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Orexo AB - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Orexo AB - Product Pipeline Review - 2014', provides an overview of the Orexo AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Orexo AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Orexo AB including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Orexo AB's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Orexo AB's pipeline products

Reasons to buy

- Evaluate Orexo AB's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Orexo AB in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Orexo AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Orexo AB and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Orexo AB
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Orexo AB and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Orexo AB Snapshot 5
Orexo AB Overview 5
Key Information 5
Key Facts 5
Orexo AB - Research and Development Overview 6
Key Therapeutic Areas 6
Orexo AB - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Orexo AB - Pipeline Products Glance 12
Orexo AB - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Orexo AB - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Orexo AB - Drug Profiles 14
alfentanil hydrochloride 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
OX-AAF 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
OX-CLI 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Orexo AB - Pipeline Analysis 17
Orexo AB - Pipeline Products by Target 17
Orexo AB - Pipeline Products by Route of Administration 18
Orexo AB - Pipeline Products by Molecule Type 19
Orexo AB - Pipeline Products by Mechanism of Action 20
Orexo AB - Recent Pipeline Updates 21
Orexo AB - Dormant Projects 23
Orexo AB - Discontinued Pipeline Products 24
Discontinued Pipeline Product Profiles 24
(omeprazole + famotidine) 24
OX-914 24
OX-CLI 24
OX-ESI 24
Orexo AB - Company Statement 25
Orexo AB - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29

List of Tables
Orexo AB, Key Information 5
Orexo AB, Key Facts 5
Orexo AB - Pipeline by Indication, 2014 7
Orexo AB - Pipeline by Stage of Development, 2014 8
Orexo AB - Monotherapy Products in Pipeline, 2014 9
Orexo AB - Out-Licensed Products in Pipeline, 2014 10
Orexo AB - Out-Licensed Products/ Combination Treatment Modalities, 2014 11
Orexo AB - Phase II, 2014 12
Orexo AB - Preclinical, 2014 13
Orexo AB - Pipeline by Target, 2014 17
Orexo AB - Pipeline by Route of Administration, 2014 18
Orexo AB - Pipeline by Molecule Type, 2014 19
Orexo AB - Pipeline Products by Mechanism of Action, 2014 20
Orexo AB - Recent Pipeline Updates, 2014 21
Orexo AB - Dormant Developmental Projects,2014 23
Orexo AB - Discontinued Pipeline Products, 2014 24
Orexo AB, Subsidiaries 26